Byline: Will Doss
-
Strengthened Microtubules Aid Cell Migration
Migrating cells use stiffened microtubules to push through tissue barriers, seeking out weak points in tissue, according to a recent study.
-
Hypoxic Inflammation Blunts Repair After Heart Attack
Inefficient cardiac repair after heart attacks is partially driven by a maladapted response to a low oxygen environment by immune cells, according to a study published in the Journal of Experimental Medicine.
-
Feinberg Celebrates Founders’ Day 2021
Founders’ Day welcomes first-year medical students to campus, honors Feinberg’s founders and marks the official start of the academic year.
-
Gene Implicated in Poor Skin Cancer Therapy Outcomes
Losing a check on T-cell activation in cutaneous T-cell lymphoma cells is associated with poor outcomes, according to a study published in Blood.
-
Using Circulating Tumor DNA to Target Immunotherapy
Using circulating tumor DNA to identify patients at risk for urothelial cancer relapse after surgical resection could help improve post-surgery treatment, according to a new study.
-
Nanoparticles Could Boost Immunotherapy
Enhancing the anti-cancer function of natural killer cells with nanoparticles could unlock their therapeutic potential, according to a Northwestern Medicine study.
-
Tackling Disparities in Internal Medicine
Blessing Aghaulor, MD, MPH, a former resident in internal medicine and current fellow in Gastroenterology and Hepatology, has conducted research on transplant outcomes and consulted about patients at the ERASE trafficking clinic in Chicago.
-
Virtual Intervention Reduces Fear of Breast Cancer Recurrence
A targeted virtual health intervention was effective in reducing fear of recurrence among breast cancer survivors.
-
Student Aims to Optimize Care Delivery
Medical student David Younessi recently authored a paper that highlighted price disparities between Medicare and VA reimbursements for several ophthalmic procedures.
-
Novel Treatments to Prevent Infections in Patients with Leukemia
Using universal myeloid progenitor cells or modified umbilical cord blood may help prevent infections in patients with leukemia, according to a pair of recent studies.
